Bifurcated endoprosthesis for treatment of aortoiliac occlusive lesions
Manuel Maynar1, Tobias Zander, Zhong Qian
1Hospiten Rambla, Las Palmas de Gran Canaria University, Santa Cruz de Tenerife, Spain.
Insights
Bifurcated stent-grafts offer a safe and effective endovascular solution for severe aortoiliac occlusive disease, improving blood flow and maintaining patency in patients with critical limb ischemia.
Area of Science:
- Vascular Surgery
- Endovascular Interventions
- Aortoiliac Disease Management
Background:
- Aortoiliac occlusive disease (AIOD) presents a significant challenge in vascular surgery.
- Severe cases, classified as TASC C or D, often require advanced treatment strategies.
Purpose of the Study:
- To evaluate the initial clinical experience with bifurcated endoprostheses for AIOD.
- To assess the safety and efficacy of this endovascular approach.
Main Methods:
- A cohort of 5 patients with severe AIOD underwent endovascular treatment using a bifurcated stent-graft (Excluder).
- Procedures involved preliminary recanalization followed by stent-graft placement.
- Patients were monitored clinically and via ultrasound post-procedure.
Main Results:
- Technical success was achieved in 100% of patients, with immediate restoration of iliac artery flow.
- No procedure-related complications or mortality were reported.
- Significant improvement in ankle-brachial index (ABI) from 0.66 to 0.94 (p<0.01), with sustained patency during a mean 17-month follow-up.
Conclusions:
- Endovascular placement of bifurcated stent-grafts is a technically feasible and effective treatment for AIOD.
- This approach demonstrates safety and efficacy in managing patients with severe aortoiliac occlusive disease.
Purpose:
To report our initial experience with a bifurcated endoprosthesis in the management of aortoiliac occlusive disease.
Methods:
From May 2001 to February 2004, 112 patients were referred to our institution for the management of aortoiliac disease. Among these, 5 (6%) patients (3 men; mean age 57.8 years) with severe ischemia owing to TASC C or D iliac occlusions were selected for endovascular treatment with a bifurcated stent-graft. An Excluder stent-graft was placed after preliminary recanalization (thrombolysis and/or balloon dilation) the day before. The patients were followed clinically and ultrasonographically every 3 months during the first year and semiannually thereafter.
Results:
Technical success was achieved in all patients. Endovascular aortoiliac bifurcation reconstruction restored iliac artery flow immediately in all cases. There were no procedure-related complications. The mean ankle-brachial index (ABI) was significantly improved, from 0.66+/-0.04 before the procedure to 0.94+/-0.06 immediately after the procedure (p<0.01). The aortoiliac reconstructions remained patent during the mean 17-month follow-up (range 3-36), and the ABIs were stable. There was no mortality or amputation required in this series.
Conclusions:
Endovascular placement of a bifurcated stent-graft appears to be technically feasible, effective, and safe in the management of aortoiliac occlusive disease.
Related Concept Videos
Peripheral Artery Disease III: Interprofessional Care
Aneurysm III: Interprofessional Care


